Skip to main content
Stock Market Live Updates: Shares of Strides Pharma opened over 8% higher after the company announced that its stepdown wholly owned subsidiary, Strides Pharma Global Pte has received tentative approval for Dolutegravir 50mg tablets from USFDA.
Comments
Post a Comment